TCT Video: Sharifi aims to TORPEDO DVT via PEVI

Click to play
TCT Video: TORPEDO Principal Investigator Mohsen Sharifi, MD
WASHINGTON, D.C.–Principal Investigator Mohsen Sharifi, MD, of the Arizona Cardiovascular Consultants and Vein clinic and professor at A.T. Still University in Mesa, Ariz., reviews the results of the TORPEDO (Thombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion) trial, the first of its kind to compare percutaneous endovenous intervention (PEVI) techniques to anticoagulation therapy alone in acute symptomatic proximal deep vein thrombosis (DVT) patients.

The results, presented as a late-breaking clinical trial at the 2010 Transcatheter Cardiovascular Therapeutics (TCT) conference this morning, showed that PEVI in combination with anticoagulation therapy may trump treatment with anticoagulation alone.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."